119 related articles for article (PubMed ID: 2085886)
21. Antitumor agents 6. Synthesis, structure-activity relationships, and biological evaluation of spiro[imidazolidine-4,3'-thieno[2,3-g]quinoline]-tetraones and spiro[thieno[2,3-g]quinoline-3,5'-[1,2,4]triazinane]-tetraones with potent antiproliferative activity.
Bolognese A; Correale G; Manfra M; Esposito A; Novellino E; Lavecchia A
J Med Chem; 2008 Dec; 51(24):8148-57. PubMed ID: 19053767
[TBL] [Abstract][Full Text] [Related]
22. SYNTHESIS AND CYTOTOXIC ACTIVITY OF NEW 5H-INDOLO[2,3-B]QUINOLINE O-AMINOGLYCOSIDES.
Badowska-Rosłonek K; Ciesielska A; Switalska M; Piskozub M; Peczyńska-Czoch W; Wietrzyk J; Kaczmarek Ł
Acta Pol Pharm; 2016; 73(3):683-92. PubMed ID: 27476287
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of new pyrazole, triazole, and thiazolidine-pyrimido [4, 5-b] quinoline derivatives with potential antitumor activity.
Abu-Hashem AA; Aly AS
Arch Pharm Res; 2012 Mar; 35(3):437-45. PubMed ID: 22477190
[TBL] [Abstract][Full Text] [Related]
24. [Synthesis and biological activity of new compounds with the 1,3-dioxol(4,5-g)quinoline structure].
Pellerano C; Savini L
Farmaco Sci; 1984 Jul; 39(7):640-8. PubMed ID: 6479323
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, cytotoxicity, DNA interaction, and topoisomerase II inhibition properties of novel indeno[2,1-c]quinolin-7-one and indeno[1,2-c]isoquinolin-5,11-dione derivatives.
Ryckebusch A; Garcin D; Lansiaux A; Goossens JF; Baldeyrou B; Houssin R; Bailly C; Hénichart JP
J Med Chem; 2008 Jun; 51(12):3617-29. PubMed ID: 18507368
[TBL] [Abstract][Full Text] [Related]
26. Methoxy- and methyl-, methoxy-5,6,11-trimethyl-6H-indolo [2,3-b]quinolinium derivatives as novel cytotoxic agents and DNA topoisomerase II inhibitors.
Kaczmarek L; Peczyńska-Czoch W; Opolski A; Wietrzyk J; Marcinkowska E; Boratyński J; Osiadacz J
Anticancer Res; 1998; 18(4C):3133-8. PubMed ID: 9713522
[TBL] [Abstract][Full Text] [Related]
27. Heterocyclic quinones. XIV. Pharmacomodulation in a series of 11H-indolo[3,2-c]quinolinediones: synthesis and cytotoxicity of 8-substituted 11H-indolo[3,2-c]quinoline-7,10-diones.
Helissey P; Giorgi-Renault S; Renault J; Cros S
Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):675-9. PubMed ID: 2752476
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of 4-quinolylazide derivatives and evaluation of their antitumor and antimicrobial activity.
Savini L; Massarelli P; Pellerano C
Farmaco; 1993 Apr; 48(4):515-28. PubMed ID: 8357467
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of new quinoline derivatives as inhibitors of human tumor cells growth.
Rashad AE; El-Sayed WA; Mohamed AM; Ali MM
Arch Pharm (Weinheim); 2010 Aug; 343(8):440-8. PubMed ID: 20803621
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of 9-anilinothiazolo[5,4-b]quinoline derivatives as potential antitumorals.
Rodríguez-Loaiza P; Quintero A; Rodríguez-Sotres R; Solano JD; Lira-Rocha A
Eur J Med Chem; 2004 Jan; 39(1):5-10. PubMed ID: 14987829
[TBL] [Abstract][Full Text] [Related]
31. Total synthesis and biological evaluation of 22-hydroxyacuminatine.
Xiao X; Antony S; Pommier Y; Cushman M
J Med Chem; 2006 Feb; 49(4):1408-12. PubMed ID: 16480276
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and antitumor cytotoxicity evaluation of pyrido[4,3,2-de]quinolines and isoquinolino[6,5,4,3-cde]quinolines.
Ding Q; Jia G; Lown JW
Anticancer Drug Des; 2000 Apr; 15(2):99-108. PubMed ID: 10901297
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and anti-cancer activity of 1,4-disubstituted imidazo[4,5-c]quinolines.
Thigulla Y; Akula M; Trivedi P; Ghosh B; Jha M; Bhattacharya A
Org Biomol Chem; 2016 Jan; 14(3):876-83. PubMed ID: 26592542
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and anticancer evaluation of certain 4-anilinofuro[2,3-b]quinoline and 4-anilinofuro[3,2-c]quinoline derivatives.
Chen YL; Chen IL; Wang TC; Han CH; Tzeng CC
Eur J Med Chem; 2005 Sep; 40(9):928-34. PubMed ID: 15913847
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of some quinoline-2(1H)-one and 1, 2, 4 - triazolo [ 4 , 3 -a ] quinoline derivatives as potent anticonvulsants.
Guan LP; Jin QH; Tian GR; Chai KY; Quan ZS
J Pharm Pharm Sci; 2007; 10(3):254-62. PubMed ID: 17727789
[TBL] [Abstract][Full Text] [Related]
36. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues.
Tardy C; Facompré M; Laine W; Baldeyrou B; García-Gravalos D; Francesch A; Mateo C; Pastor A; Jiménez JA; Manzanares I; Cuevas C; Bailly C
Bioorg Med Chem; 2004 Apr; 12(7):1697-712. PubMed ID: 15028262
[TBL] [Abstract][Full Text] [Related]
37. Biological evaluation of omega-(dialkylamino)alkyl derivatives of 6H-indolo[2,3-b]quinoline--novel cytotoxic DNA topoisomerase II inhibitors.
Godlewska J; Luniewski W; Zagrodzki B; Kaczmarek L; Bielawska-Pohl A; Dus D; Wietrzyk J; Opolski A; Siwko M; Jaromin A; Jakubiak A; Kozubek A; Peczyñska-Czoch W
Anticancer Res; 2005; 25(4):2857-68. PubMed ID: 16080538
[TBL] [Abstract][Full Text] [Related]
38. Investigating the antiproliferative activity of quinoline-5,8-diones and styrylquinolinecarboxylic acids on tumor cell lines.
Podeszwa B; Niedbala H; Polanski J; Musiol R; Tabak D; Finster J; Serafin K; Milczarek M; Wietrzyk J; Boryczka S; Mol W; Jampilek J; Dohnal J; Kalinowski DS; Richardson DR
Bioorg Med Chem Lett; 2007 Nov; 17(22):6138-41. PubMed ID: 17904844
[TBL] [Abstract][Full Text] [Related]
39. Synthsis and antitumor properties of bis(quinaldine) derivatives.
Sinha BK; Philen RM; Sato R; Cysyk RL
J Med Chem; 1977 Nov; 20(11):1528-31. PubMed ID: 915919
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and Anti-Tumor Activities of 4-Anilinoquinoline Derivatives.
Liu D; Luan T; Kong J; Zhang Y; Wang HF
Molecules; 2015 Dec; 21(1):E21. PubMed ID: 26703559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
